A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC)Karin Purshouse, Jeremy Crew, Caroline Haddon et al.|European Urology Supplements|2019Cited by 1